@article{82de67375f0d40d2b43a62485f300733,
title = "Chile's National Advisory Committee on Immunization (CAVEI): Evidence-based recommendations for public policy decision-making on vaccines and immunization",
abstract = "A National Immunization Technical Advisory Group (NITAG) provides independent, evidence–based recommendations to the Ministry of Health for immunization programmes and policy formulation. In this article, we describe the structure, functioning and work processes of Chile's NITAG (CAVEI) and assess its functionality, quality of work processes and outputs, and integration of the committee into the Ministry of Health policy process using the Assessment tool for National Immunization Technical Advisory Groups. Among its strengths, CAVEI's administrative and work plasticity allows it to respond in a timely manner to the Ministry of Health's requests and proactively raise subjects for review. Representation of multiple areas of expertise within the committee makes CAVEI a robust and balanced entity for the development of evidence–based comprehensive recommendations. High ranking profile of the Secretariat structure furthers CAVEI's competences in policymaking and serves as a bridge between the committee and international initiatives in the field of immunizations.",
keywords = "Chile, Evidence-based recommendations, Immunization decision-making, Immunization policy, National Immunization Technical Advisory Group",
author = "Jeannette Dabanch and Cecilia Gonz{\'a}lez and Jaime Cerda and Johanna Acevedo and Mario Calvo and Eduardo D{\'i}az and Mar{\'i}a Endeiza and Jaime Inostroza and Jaime Rodr{\'i}guez and Adiela Salda{\~n}a and Solange Santillana and {El Omeiri}, Nathalie and Magdalena Bast{\'i}as",
note = "Funding Information: We thank PAHO's Department of Family, Health Promotion and Life Course for facilitating this evaluation, the United States Centers for Disease Control and Prevention (CDC), Global Immunization Division, especially Abigail Sheffer and Kathy Cavallaro for their technical and financial support, the Argentinian Institute of Clinical and Effectiveness Health Policy, for their support during the evaluation (Juan Alonso, Maria Belizan and Daniel Jones), and the Global NITAGs Network, and its secretariat at the World Health Organization for their inputs and collaboration. JD has no conflicts of interests. CG has no conflicts of interests. JC has no conflicts of interests. JA has no conflicts of interests. MC has no conflicts of interests. ED has no conflicts of interests. ME works as immunization coordinator for a private hospital that purchases vaccines from different manufacturers and declares to have no conflicts of interests relevant to this paper. JI has no conflicts of interests. JR has no conflicts of interests. AS has no conflicts of interests. SS has no conflicts of interests. NE has no conflicts of interests. MB has no conflicts of interests. Publisher Copyright: {\textcopyright} 2019 The Authors",
year = "2019",
month = jul,
day = "26",
doi = "10.1016/j.vaccine.2019.06.069",
language = "English",
volume = "37",
pages = "4646--4650",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "32",
}
